The report notes that the possibility of the prolonged West Asia conflict poses sizeable upside risks to India’s CAD in FY27 ...
At the upper end of the price band, Powerica is expected to command a post-issue market capitalisation of Rs 4,998.6 crore ...
The report says that Indian lab-grown diamond exports have grown six-fold from USD 225 million in FY2019 to USD 1,207 million ...
The number of Indian firms in the global top 500 has also declines to 11, down from 15 at the start of 2026 and 18 in ...
Technology stocks lead the gains, with the Nifty IT rising 3.7 per cent, as brokerage CLSA downplayed concerns around disruption from new AI tools ...
The report notes that CCI initiated the probe in August after a company approached it under its leniency programme ...
India’s securitisation market faces greater risk from weak counterparties than from underlying asset quality, according to a report by India Ratings and Research (Ind-Ra), which ...
Nirmala Sitharaman warns insurers against misconduct, highlights penalties, and announces insurance coverage expansion to ...
Subsidiaries secure multi-state consultancy projects spanning infrastructure planning, digital governance, financial advisory ...
NCLT approves Adani Enterprises’ Rs 15,000 crore resolution plan for Jaiprakash Associates, marking a key milestone in one of ...
Rivotril is an innovator formulation of clonazepam, widely prescribed for neurological and psychiatric conditions.
The stake purchase comes amid a sizeable block deal on Tuesday, where three entities collectively offloaded around 4.6 per cent of the company’s equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results